Rates of CTL Killing in Persistent Viral Infection In Vivo

PLoS Computational Biology

Volumn 10, Issue 4, 2014, Pages

  Elemans, Marjet ^a   Florins, Arnaud ^b   Willems, Luc ^b   Asquith, Becca ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXICITY; DISEASES; T-CELLS;

BOVINE LEUKEMIA VIRUS; CELL-BE; CELL/B.E; CELL/BE; CYTOTOXIC T LYMPHOCYTES; IN-VIVO; INFECTED CELLS; VIRAL INFECTIONS; VIRUS INFECTION; VIRUS-INFECTED CELLS;

VIRUSES;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOVINE LEUKEMIA VIRUS; CD8+ T LYMPHOCYTE; CELL KILLING; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; EX VIVO STUDY; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; IN VIVO STUDY; INFECTION RATE; LYMPHOCYTE FUNCTION; NONHUMAN; SHEEP; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION; ANIMAL; BIOLOGICAL MODEL; BOVINAE; CYTOTOXICITY; ENZOOTIC BOVINE LEUKOSIS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOLOGY; SHEEP DISEASE; VIROLOGY;

ANIMALS; CATTLE; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; ENZOOTIC BOVINE LEUKOSIS; HTLV-I INFECTIONS; HUMANS; MODELS, BIOLOGICAL; SHEEP; SHEEP DISEASES;

EID: 84901364790     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1003534     Document Type: Article

References (57)

1. Barber DL, Wherry EJ, Masopust D, Zhu BG, Allison JP, et al. (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
2. Regoes RR, Barber DL, Ahmed R, Antia R, (2007) Estimation of the rate of killing by cytotoxic T lymphocytes in vivo. Proceedings of the National Academy of Sciences 104: 1599-1603.
3. Yates A, Graw F, Barber DL, Ahmed R, Regoes RR, et al. (2007) Revisiting Estimates of CTL Killing Rates In Vivo. PLoS One 2: e1301.
4. Ganusov VV, De Boer RJ, (2008) Estimating In Vivo Death Rates of Targets due to CD8 T-Cell-Mediated Killing. Journal of Virology 82: 11749-11757.
5. Graw F, Richter K, Oxenius A, Regoes RR, (2011) Comparison of cytotoxic T lymphocyte efficacy in acute and persistent lymphocytic choriomeningitis virus infection. Proceedings of the Royal Society B-Biological Sciences 278: 3395-3402.
6. Ganusov VV, Lukacher AE, Byers AM, (2010) Persistence of viral infection despite similar killing efficacy of antiviral CD8(+) T cells during acute and chronic phases of infection. Virology 405: 193-200.
7. Wick WD, Yang OO, Corey L, Self SG, (2005) How many human immunodeficiency virus type 1-infected target cells can a cytotoxic T-lymphocyte kill? The Journal of Virology 79: 13579-13586.
8. Brodie SJ, Lewinsohn DA, Patterson BK, Jiyamapa D, Krieger J, et al. (1999) In vivo migration and function of transferred HIV-1-specific cytotoxic T cells. Nature Medicine 5: 34-41.
9. Asquith B, Edwards CTT, Lipsitch M, McLean AR, (2006) Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biology 4: 583-592.
10. Goonetilleke N, Liu MKP, Salazar-Gonzalez JF, Ferrari G, Giorgi E, et al. (2009) The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. Journal of Experimental Medicine 206: 1253-1272.
11. Asquith B, McLean AR, (2007) In vivo CD8(+) T cell control of immunodeficiency virus infection in humans and macaques. Proceedings of the National Academy of Sciences of the United States of America 104: 6365-6370.
12. Mandl JN, Regoes RR, Garber DA, Feinberg MB, (2007) Estimating the effectiveness of simian immunodeficiency virus-specific CD8(+) T cells from the dynamics of viral immune escape. Journal of Virology 81: 11982-11991.
13. Petravic J, Loh L, Kent SJ, Davenport MP, (2008) CD4(+) target cell availability determines the dynamics of immune escape and reversion in vivo. Journal of Virology 82: 4091-4101.
14. Ganusov VV, Goonetilleke N, Liu MKP, Ferrari G, Shaw GM, et al. (2011) Fitness Costs and Diversity of the Cytotoxic T Lymphocyte (CTL) Response Determine the Rate of CTL Escape during Acute and Chronic Phases of HIV Infection. Journal of Virology 85: 10518-10528.
15. Masopust D, Murali-Krishna K, Ahmed R, (2007) Quantitating the magnitude of the lymphocytic choriomeningitis virus-specific CD8 T-cell response: It is even bigger than we thought. Journal of Virology 81: 2002-2011.
16. Kotturi MF, Peters B, Buendia-Laysa F Jr, Sidney J, Oseroff C, et al. (2007) The CD8(+) T-cell response to lymphocytic choriomeningitis virus involves the L antigen: Uncovering new tricks for an old virus. Journal of Virology 81: 4928-4940.
17. Markowitz M, Louie M, Hurley A, Sun E, Di Mascio M, (2003) A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-Cell decay in vivo. Journal of Virology 77: 5037-5038.
18. Elemans M, Thiebaut R, Kaur A, Asquith B, (2011) Quantification of the Relative Importance of CTL, B Cell, NK Cell, and Target Cell Limitation in the Control of Primary SIV-Infection. PLoS Computational Biology 7: e1001103.
19. Elemans M, al Basatena N-KS, Klatt NR, Gkekas C, Silvestri G, et al. (2011) Why Don't CD8+T Cells Reduce the Lifespan of SIV-Infected Cells In Vivo? PLoS Computational Biology 7: e1002200.
20. Willems L, Portetelle D, Kerkhofs P, Chen G, Burny A, et al. (1992) In vivo transfection of Bovine Leukemia Provirus into sheep. Virology 189: 775-777.
21. Florins A, de Brogniez A, Elemans M, Bouzar A-B, François C, et al. (2012) Viral Expression Directs the Fate of B Cells in Bovine Leukemia Virus-Infected Sheep. Journal of Virology 86: 621-624.
22. Trenn G, Taffs R, Hohman R, Kincaid R, Shevach EM, et al. (1989) Biochemical characterization of the inhibitory effect of CsA on cytolytic T lymphocyte effector functions. J Immunol 142: 3796-3802.
23. Zeyda M, Geyeregger R, Poglitsch M, Weichhart T, Zlabinger GJ, et al. (2007) Impairment of T cell interactions with antigen-presenting cells by immunosuppressive drugs reveals involvement of calcineurin and NF-kappa B in immunological synapse formation. Journal of Leukocyte Biology 81: 319-327.
24. Zhan XY, Brown B, Slobod KS, Hurwitz JL, (2003) Inhibition of ex vivo-expanded cytotoxic T-lymphocyte function by high-dose cyclosporine. Transplantation 76: 739-741.
25. Dutz JP, Fruman DA, Burakoff SJ, Bierer BE, (1993) A ROLE FOR CALCINEURIN IN DEGRANULATION OF MURINE CYTOTOXIC T-LYMPHOCYTES. Journal of Immunology 150: 2591-2598.
26. Weigelin B, Friedl P, (2010) A three-dimensional organotypic assay to measure target cell killing by cytotoxic T lymphocytes. Biochem Pharmacol 80: 2087-2091.
27. Matsuoka M, (2003) Human T-cell leukemia virus type I and adult T-cell leukemia. Oncogene 22: 5131-5140.
28. Debacq C, Gillet N, Asquith B, Sanchez-Alcaraz MT, Florins A, et al. (2006) Peripheral blood B-cell death compensates for excessive proliferation in lymphoid tissues and maintains homeostasis in bovine leukemia virus-infected sheep. J Virol 80: 9710-9719.
29. Andrade WN, Johnston MG, Hay JB, (1998) The relationship of blood lymphocytes to the recirculating lymphocyte pool. Blood 91: 1653-1661.
30. Olindo S, Belrose G, Gillet N, Rodriguez S, Boxus M, et al. (2011) Safety of long-term treatment of HAM/TSP patients with valproic acid. Blood 118: 6306-6309.
31. Mosley AJ, Meekings KN, McCarthy C, Shepherd D, Cerundolo V, et al. (2006) Histone deacetylase inhibitors increase virus gene expression but decrease CD8(+) cell antiviral function in HTLV-1 infection. Blood 108: 3801-3807.
32. Lezin A, Gillet N, Olindo S, Signate A, Grandvaux N, et al. (2007) Histone deacetylase-mediated transcriptional activation reduces proviral loads in HTLV-1-associated myelopathy/tropical spastic paraparesis patients. Blood 110: 3722-3728.
33. Kubota R, Fujiyoshi T, Izumo S, Yashiki S, Maruyama I, et al. (1993) Fluctuation of HTLV-1 proviral DNA in peripheral-blood mononuclear-cells of HTLV-1-associated myelopathy. Journal of Neuroimmunology 42: 147-154.
34. Kwaan N, Lee T-H, Chafets DM, Nass C, Newman B, et al. (2006) Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data. Journal of Infectious Diseases 194: 1557-1564.
35. Defoiche J (2009) Measurement in vivo of cell turnover in patients with chronic lymphocytic leukaemia. Gembloux, Belgium: Faculté Universitaire des Sciences Agronomiques, Université de Liège. 99 p.
36. Hanon E, Hall S, Taylor GP, Saito M, Davis R, et al. (2000) Abundant Tax protein expression in CD4+T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 95: 1386-1392.
37. Parker CE, Nightingale S, Taylor GP, Weber J, Bangham CRM, (1994) CIRCULATING ANTI-TAX CYTOTOXIC T-LYMPHOCYTES FROM HUMAN T-CELL LEUKEMIA-VIRUS TYPE I-INFECTED PEOPLE, WITH AND WITHOUT TROPICAL SPASTIC PARAPARESIS, RECOGNIZE MULTIPLE EPITOPES SIMULTANEOUSLY. Journal of Virology 68: 2860-2868.
38. Daenke S, Kermode AG, Hall SE, Taylor G, Weber J, et al. (1996) High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis. Virology 217: 139-146.
39. Bonaparte MI, Barker E, (2004) Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules. Blood 104: 2087-2094.
40. Allen TM, O'Connor DH, Jing PC, Dzuris JL, Mothe BR, et al. (2000) Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407: 386-390.
41. Yang OO, Kalams SA, Rosenzweig M, Trocha A, Jones N, et al. (1996) Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes. J Virol 70: 5799-5806.
42. Asquith B, Mosley AJ, Barfield A, Marshall SE, Heaps A, et al. (2005) A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load. J Gen Virol 86: 1515-1523.
43. Barber DL, Wherry EJ, Ahmed R, (2003) Cutting edge: rapid in vivo killing by memory CD8 T cells. J Immunol 171: 27-31.
44. Borghans JAM, de Boer RJ, (2007) Quantification of T-cell dynamics: from telomeres to DNA labeling. Immunological Reviews 216: 35-47.
45. Westera L, Drylewicz J, den Braber I, Mugwagwa T, van der Maas I, et al. (2013) Closing the gap between T-cell life span estimates from stable isotope-labeling studies in mice and men. Blood 122: 2205-2212.
46. Klatt NR, Shudo E, Ortiz AM, Engram JC, Paiardini M, et al. (2010) CD8+ lymphocytes control viral replication in SIV-mac239-infected rhesus macaques without decreasing the lifespan of productively infected cells. PLoS Pathogens 6: e1000747-e1000747.
47. Wong JK, Strain MC, Porrata R, Reay E, Sankaran-Walters S, et al. (2010) In Vivo CD8+ T-Cell Suppression of SIV Viremia Is Not Mediated by CTL Clearance of Productively Infected Cells. PLoS Pathogens 6: e1000748.
48. Guidotti LG, Chisari FV, (1996) To kill or to cure: options in host defense against viral infection. Current Opinion in Immunology 8: 478-483.
49. Seich al Basatena K-N, Chatzimichalis K, Graw F, Frost S, Regoes RR, et al. (2013) Can Non-Lytic CD8+ T cells Drive HIV-1 Escape? PLOS Pathogens 9: e1003656.
50. Dehee A, Cesaire R, Desire N, Lezin A, Bourdonne O, et al. (2002) Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay. Journal of Virological Methods 102: 37-51.
51. Ganusov VV, Barber DL, De Boer RJ, (2011) Killing of Targets by CD8(+) T Cells in the Mouse Spleen Follows the Law of Mass Action. PLoS One 6: e15959.
52. Asquith B, Debacq C, Florins A, Gillet N, Sanchez-Alcaraz T, et al. (2006) Quantifying lymphocyte kinetics in vivo using carboxyfluorescein diacetate succinimidyl ester (CFSE). Proceedings of the Royal Society B-Biological Sciences 273: 1165-1171.
53. Soetaert K, Petzoldt T, (2010) Inverse Modelling, Sensitivity and Monte Carlo Analysis in R Using Package FME. Journal of Statistical Software 33: 1-28.
54. Chernick MR (1999) Bootstrap Methods: A Practitioner's Guide. New Jersey: Wiley & Sons.
55. Efron B (1982) The Jackknife, the Bootstrap and Other Resampling Plans. Philadelphia: Society for Industrial and Applied Mathematics.
56. Asquith B, Zhang Y, Mosley AJ, de Lara CM, Wallace DL, et al. (2007) In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection. Proceedings of the National Academy of Sciences 104: 8035-8040.
57. Macallan DC, Asquith B, Irvine AJ, Wallace DL, Worth A, et al. (2003) Measurement and modeling of human T cell kinetics. European Journal of Immunology 33: 2316-2326.